The results showed that ZFX expression was inhibited effectively in both CML and NBM CD34+ cells to a similar extent (Fig. 2A), and ZFX silencing significantly suppressed the CFC production of CML CD34+ cells and NBM CD34+ cells. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.